Zenzi Pharmaceutical Industries

What Zenzi Pharmaceutical Industries does

Zenzi Pharmaceutical Industries Pvt. Ltd. is a Mumbai-headquartered pharmaceutical contract development and manufacturing organization (CDMO) founded in 2005. The company operates a single 14,000 square meter cGMP-approved manufacturing facility in Murbad, Thane, India, producing both branded and non-branded generic medicines for pharmaceutical company clients across Europe, Latin America, Africa, and Asia. The company maintains a unified cGMP standard encompassing US GMP, EU GMP, Indian GMP, and WHO GMP guidelines, with explicit EU and WHO regulatory approvals for its manufacturing operations.

The company's product portfolio spans two primary segments: General Oral Solid Dosages (tablets and capsules) and Injectables (vials, ampoules, and lyophilized formulations). It claims one of the world's largest capacities for steroid and hormone manufacturing and operates specialized containment capability for highly potent formulations up to OEL 4 safety classification. Annual production capacity reaches 600 million tablets, 290 million capsules, 35 million vials, 85 million ampoules, and 30 million lyophilized vials. The facility is equipped with granulation, drying, compaction, blending, compression, coating, blistering, sterile filling, and lyophilization equipment, supported by a pilot-scale kilo-lab facility and in-house analytical capabilities including HPLC and Gas Chromatography. R&D is staffed by over 15 scientists focused on formulation development.

The business model is B2B contract manufacturing with quote-based pricing. Zenzi does not sell directly to consumers but manufactures to client specifications under contractual agreements. The go-to-market motion is enterprise-focused, relying on direct business development outreach ([email protected]), industry trade show participation (CPHI Frankfurt 2025), and the company website for client acquisition. The company is privately held with no disclosed institutional investment, funding rounds, or M&A activity.

Name

Zenzi Pharmaceutical Industries

Legal name

Zenzi Pharmaceutical Industries Private limited

Website

https://zenzi.in

Company type

Private

Founded year

2005

Operating status

Operating

Short description

Zenzi Pharmaceutical Industries is a Mumbai-based GMP-licensed pharmaceutical contract manufacturer producing generic oral solid dosages, injectables, highly potent formulations, and steroids/hormones for global pharma clients across Europe, Latin America, Africa, and Asia.

Ownership category

akta.pro rank

Product category

Pharmaceutical Contract Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Contract Development & Manufacturing for Generics (CDMO/CMO) (HLAIABAI)

akta.pro secondary industry

Specialty Injectable & Infusion Therapies (Cross-therapeutic) (HLAIACAO)

Keywords

• Contract pharmaceutical manufacturing
• Generic medicine manufacturing
• Oral solid dosage manufacturing
• Sterile injectable manufacturing
• Potent formulation manufacturing

Headquarters

HQ city

Mumbai

HQ country

India

HQ region

Asia

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Contract Manufacturing Services: Revenue generated through contract manufacturing of pharmaceutical products for pharmaceutical companies worldwide. The company manufactures both branded and non-branded generics for clients, providing end-to-end manufacturing services including oral solid dosages and injectables.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Core offering

Zenzi Pharmaceutical Industries is a cGMP-licensed contract manufacturer that develops and produces generic pharmaceutical products for pharmaceutical company clients worldwide. Core output spans General Oral Solid Dosages (tablets and capsules), sterile Injectables (vials, ampoules, lyophilized products), and specialized categories including highly potent formulations up to OEL 4 and steroids and hormones, backed by a pilot-scale kilo-lab facility for formulation development and analytical method support.

Product overview

Zenzi Pharmaceuticals operates as a contract manufacturer offering two primary product categories: General Oral Solid Dosages (GOSD) comprising tablets and capsules, and Injectables including vials, ampoules, and lyophilized products. The company also specializes in highly potent formulations up to OEL 4 and steroid/hormone manufacturing with one of the world's largest capacities. A pilot-scale kilo-lab facility supports formulation development and testing before scale-up to full manufacturing.

Differentiator

Problem solved

Functional benefit

Quantifiable outcome

• Production capacity of 600 million tablets, 290 million capsules annually
• +2 more outcomes

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Scale indicators5 records

Recent moves4 records

Expansion highlights4 records

Market position

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Zenzi Pharmaceutical Industries